Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥9.09 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	268.50
Forward PE
Price to Sales TTM	CN¥12.16
Price to Book MRQ	CN¥3.81
Enterprise to Revenue	10.54
Enterprise to EBITDA	-148.91

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-06-30
Profit Margin	-8.81%
Operating Margin	-9.29%
Return on Assets TTM	-2.58%
Return on Equity TTM	-2.73%

Income Statement

Revenue TTM	CN¥711,631,680
Revenue per Share TTM	CN¥0.86
Quarterly Revenue Growth	14.40%
Gross Profit TTM	CN¥638,198,272
EBITDA	CN¥59,304,895
Net Income to Common TTM	CN¥-62,671,232
Diluted EPS TTM	CN¥-0.02
Quarterly Earnings Growth YoY	-21.94%

Balance Sheet

Total Cash MRQ	CN¥1,118,649,216
Total Cash per Share MRQ	CN¥1.08
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.71
Current Ratio MRQ	8.68
Book Value per Share MRQ	CN¥2.18

Cash Flow

Operating Cash Flow TTM	CN¥149,625,312
Levered Free Cash Flow TTM	CN¥75,869,800

688505 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	1,043,000,000
Float Shares	321,814,174
Avg 10 Volume	2,315,238
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	62.77%
% Held by Institutions	0.17%

Stock Price Summary

Beta	-0.06
Fifty Two Week Low	CN¥6.73
Fifty Two Week High	CN¥11.69
Fifty Two Week Change	10.48%
Day 50 MA	CN¥8.69
Day 200 MA	CN¥8.91

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.12
Forward Annual Dividend Yield	1.45%
Trailing Annual Dividend Rate	CN¥0.03
Trailing Annual Dividend Yield	0.36%
Payout Ratio	234.79%
Dividend Date
Ex Dividend Date	2025-07-18
Last Split Factor
Last Split Date